ArticleDermatology and therapy2023

Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial.

Tsen-Fang Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.